Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Cardiac rhythm device surgery with uninterrupted oral anticoagulation.

Tyagi G, Pai SM, Pai RG.

Future Cardiol. 2013 Nov;9(6):763-6. doi: 10.2217/fca.13.80.

PMID:
24180532
2.

Pacemaker or defibrillator surgery without interruption of anticoagulation.

Birnie DH, Healey JS, Wells GA, Verma A, Tang AS, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leiria TL, Essebag V; BRUISE CONTROL Investigators.

N Engl J Med. 2013 May 30;368(22):2084-93. doi: 10.1056/NEJMoa1302946. Epub 2013 May 9.

3.

Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies.

Proietti R, Porto I, Levi M, Leo A, Russo V, Kalfon E, Biondi-Zoccai G, Roux JF, Birnie DH, Essebag V.

Eur Rev Med Pharmacol Sci. 2015 Apr;19(8):1461-79. Review.

4.

Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices.

Ghanbari H, Phard WS, Al-Ameri H, Latchamsetty R, Jongnarngsin K, Crawford T, Good E, Chugh A, Oral H, Bogun F, Morady F, Pelosi F Jr.

Am J Cardiol. 2012 Nov 15;110(10):1482-8. doi: 10.1016/j.amjcard.2012.06.057. Epub 2012 Aug 17. Review.

PMID:
22906894
5.

Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin.

Tischenko A, Gula LJ, Yee R, Klein GJ, Skanes AC, Krahn AD.

Am Heart J. 2009 Aug;158(2):252-6. doi: 10.1016/j.ahj.2009.06.005.

PMID:
19619702
6.

Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.

Ahmed I, Gertner E, Nelson WB, House CM, Dahiya R, Anderson CP, Benditt DG, Zhu DW.

Heart Rhythm. 2010 Jun;7(6):745-9. doi: 10.1016/j.hrthm.2010.02.018. Epub 2010 Feb 20.

PMID:
20176137
7.

ACP Journal Club. Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery.

Deloughery T.

Ann Intern Med. 2013 Aug 20;159(4):JC7. doi: 10.7326/0003-4819-159-4-201308200-02007. No abstract available.

PMID:
24026283
8.

Bridge or continue Coumadin for device surgery: a randomized controlled trial rationale and design.

Birnie D, Healey JS, Krahn A, Essebag V, Sivakumaran S, Tang A, Simpson C.

Curr Opin Cardiol. 2009 Jan;24(1):82-7. Review.

PMID:
19102040
9.

Device surgery without interruption of anticoagulation.

Korantzopoulos P.

N Engl J Med. 2013 Oct 17;369(16):1571. doi: 10.1056/NEJMc1310241#SA3. No abstract available.

PMID:
24131192
10.

Device surgery without interruption of anticoagulation.

Golwala H.

N Engl J Med. 2013 Oct 17;369(16):1571. doi: 10.1056/NEJMc1310241#SA2. No abstract available.

PMID:
24131191
11.

Device surgery without interruption of anticoagulation.

Skeith L, Kovacs MJ, Douketis JD.

N Engl J Med. 2013 Oct 17;369(16):1570-1. doi: 10.1056/NEJMc1310241#SA1. No abstract available.

PMID:
24131190
12.

Device surgery without interruption of anticoagulation.

Birnie DH, Healey JS, Essebag V.

N Engl J Med. 2013 Oct 17;369(16):1571-2. doi: 10.1056/NEJMc1310241. No abstract available.

13.

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.

Essebag V, Healey JS, Ayala-Paredes F, Kalfon E, Coutu B, Nery P, Verma A, Sapp J, Philippon F, Sandhu RK, Coyle D, Eikelboom J, Wells G, Birnie DH.

Am Heart J. 2016 Mar;173:102-7. doi: 10.1016/j.ahj.2015.12.007. Epub 2015 Dec 19.

PMID:
26920602
14.

A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.

Michaud GF, Pelosi F Jr, Noble MD, Knight BP, Morady F, Strickberger SA.

J Am Coll Cardiol. 2000 Jun;35(7):1915-8.

15.

Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.

Jennings JM, Robichaux R, McElderry HT, Plumb VJ, Gunter A, Doppalapudi H, Osorio J, Yamada T, Kay GN.

J Cardiovasc Electrophysiol. 2013 Oct;24(10):1125-9. doi: 10.1111/jce.12214. Epub 2013 Jul 25.

PMID:
23889767
16.

Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.

Chen HC, Chen YL, Guo BF, Tsai TH, Chang JP, Pan KL, Lin YS, Chen MC.

Can J Cardiol. 2013 Sep;29(9):1110-7. doi: 10.1016/j.cjca.2012.12.014. Epub 2013 Mar 6.

PMID:
23474139
17.

Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial.

Schulman S, Healey JS, Douketis JD, Delaney J, Morillo CA.

Thromb Res. 2014 Oct;134(4):814-8. doi: 10.1016/j.thromres.2014.07.028. Epub 2014 Aug 1.

PMID:
25127655
18.

Cost effectiveness of continued-warfarin versus heparin-bridging therapy during pacemaker and defibrillator surgery.

Coyle D, Coyle K, Essebag V, Birnie DH, Ahmad K, Toal S, Sapp J, Healey JS, Verma A, Wells G, Krahn AD.

J Am Coll Cardiol. 2015 Mar 10;65(9):957-9. doi: 10.1016/j.jacc.2014.11.060. No abstract available.

19.

Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.

Airaksinen KE, Korkeila P, Lund J, Ylitalo A, Karjalainen P, Virtanen V, Raatikainen P, Koivisto UM, Koistinen J.

Int J Cardiol. 2013 Oct 9;168(4):3679-82. doi: 10.1016/j.ijcard.2013.06.022. Epub 2013 Jul 9.

PMID:
23849104
20.

Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.

Ghanbari H, Feldman D, Schmidt M, Ottino J, Machado C, Akoum N, Wall TS, Daccarett M.

Pacing Clin Electrophysiol. 2010 Apr;33(4):400-6. doi: 10.1111/j.1540-8159.2010.02703.x. Epub 2010 Feb 18.

PMID:
20180915

Supplemental Content

Support Center